Insulin Market Report

Europe Insulin Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 20, 2020
  • PAGES：142
  • REPORT CODE：GMM569857
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.

    The Insulin market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Insulin Market Segmentations:

    By Player:

    • Disha Pharmaceutical Group

    • Novartis

    • GEA

    • Dongbao

    • MannKind

    • Gan & Lee

    • Emisphere

    • Boehringer Ingelheim

    • Merck

    • United Laboratories (TUL)

    • Sanofi

    • Eli Lilly

    • Bristol-Myers Squibb

    • Novo Nordisk

    • Takeda Pharmaceutical Company

    • Shihuida PHARMA Group

    • Bioton

    • Salix Pharmaceuticals

    • Henan Tian Fang Pharmaceutical

    By Type:

    • Ultra-short-acting insulin

    • Short-acting insulin

    • In effect insulin

    • Long-acting insulin

    By End-User:

    • Type 1 diabetes

    • Type 2 diabetes

    • Others diabetes

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Insulin Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Insulin Market Size and Growth Rate of Ultra-short-acting insulin from 2014 to 2026

    • 1.3.2 Europe Insulin Market Size and Growth Rate of Short-acting insulin from 2014 to 2026

    • 1.3.3 Europe Insulin Market Size and Growth Rate of In effect insulin from 2014 to 2026

    • 1.3.4 Europe Insulin Market Size and Growth Rate of Long-acting insulin from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Insulin Market Size and Growth Rate of Type 1 diabetes from 2014 to 2026

    • 1.4.2 Europe Insulin Market Size and Growth Rate of Type 2 diabetes from 2014 to 2026

    • 1.4.3 Europe Insulin Market Size and Growth Rate of Others diabetes from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Insulin Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Insulin Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Insulin by Major Types

      • 3.4.1 Market Size and Growth Rate of Ultra-short-acting insulin

      • 3.4.2 Market Size and Growth Rate of Short-acting insulin

      • 3.4.3 Market Size and Growth Rate of In effect insulin

      • 3.4.4 Market Size and Growth Rate of Long-acting insulin

    4 Segmentation of Insulin Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Insulin by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Type 1 diabetes for Construction

      • 4.4.2 Market Size and Growth Rate of Type 2 diabetes for Construction

      • 4.4.3 Market Size and Growth Rate of Others diabetes for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Insulin Production Analysis by Top Regions

    • 5.2 Europe Insulin Consumption Analysis by Top Regions

    • 5.3 Europe Insulin Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Insulin Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Insulin Production, Import, Consumption and Export Analysis

      • 5.3.3 France Insulin Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Insulin Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Insulin Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Insulin Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Insulin Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Insulin Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Insulin Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Insulin Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Insulin Production, Import, Consumption and Export Analysis

    6 Product Circulation of Insulin Market among Top Countries

    • 6.1 Top 5 Export Countries in Insulin Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Insulin Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Insulin Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Insulin Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Insulin Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Insulin Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Insulin Landscape Analysis

    • 7.1 Germany Insulin Landscape Analysis by Major Types

    • 7.2 Germany Insulin Landscape Analysis by Major End-Users

    8. UK Insulin Landscape Analysis

    • 8.1 UK Insulin Landscape Analysis by Major Types

    • 8.2 UK Insulin Landscape Analysis by Major End-Users

    9. France Insulin Landscape Analysis

    • 9.1 France Insulin Landscape Analysis by Major Types

    • 9.2 France Insulin Landscape Analysis by Major End-Users

    10. Italy Insulin Landscape Analysis

    • 10.1 Italy Insulin Landscape Analysis by Major Types

    • 10.2 Italy Insulin Landscape Analysis by Major End-Users

    11. Spain Insulin Landscape Analysis

    • 11.1 Spain Insulin Landscape Analysis by Major Types

    • 11.2 Spain Insulin Landscape Analysis by Major End-Users

    12. Poland Insulin Landscape Analysis

    • 12.1 Poland Insulin Landscape Analysis by Major Types

    • 12.2 Poland Insulin Landscape Analysis by Major End-Users

    13. Russia Insulin Landscape Analysis

    • 13.1 Russia Insulin Landscape Analysis by Major Types

    • 13.2 Russia Insulin Landscape Analysis by Major End-Users

    14. Switzerland Insulin Landscape Analysis

    • 14.1 Switzerland Insulin Landscape Analysis by Major Types

    • 14.2 Switzerland Insulin Landscape Analysis by Major End-Users

    15. Turkey Insulin Landscape Analysis

    • 15.1 Turkey Insulin Landscape Analysis by Major Types

    • 15.2 Turkey Insulin Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Landscape Analysis by Top Countries

      • 16.3.1 Denmark Insulin Market Volume and Growth Rate

      • 16.3.2 Finland Insulin Market Volume and Growth Rate

      • 16.3.3 Norway Insulin Market Volume and Growth Rate

      • 16.3.4 Sweden Insulin Market Volume and Growth Rate

      • 16.3.6 Iceland Insulin Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Insulin Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Insulin Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Insulin Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Insulin Landscape Analysis by Top Countries

      • 17.3.1 Belgium Insulin Market Volume and Growth Rate

      • 17.3.2 Netherlands Insulin Market Volume and Growth Rate

      • 17.3.3 Luxembourg Insulin Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Insulin Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Insulin Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Insulin Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Insulin Landscape Analysis by Top Countries

      • 18.3.1 Estonia Insulin Market Volume and Growth Rate

      • 18.3.2 Latvia Insulin Market Volume and Growth Rate

      • 18.3.3 Lithuania Insulin Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Disha Pharmaceutical Group

      • 19.1.1 Disha Pharmaceutical Group Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Novartis

      • 19.2.1 Novartis Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GEA

      • 19.3.1 GEA Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Dongbao

      • 19.4.1 Dongbao Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 MannKind

      • 19.5.1 MannKind Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Gan & Lee

      • 19.6.1 Gan & Lee Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Emisphere

      • 19.7.1 Emisphere Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Boehringer Ingelheim

      • 19.8.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Merck

      • 19.9.1 Merck Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 United Laboratories (TUL)

      • 19.10.1 United Laboratories (TUL) Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Sanofi

      • 19.11.1 Sanofi Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Eli Lilly

      • 19.12.1 Eli Lilly Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Bristol-Myers Squibb

      • 19.13.1 Bristol-Myers Squibb Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Novo Nordisk

      • 19.14.1 Novo Nordisk Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Takeda Pharmaceutical Company

      • 19.15.1 Takeda Pharmaceutical Company Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Shihuida PHARMA Group

      • 19.16.1 Shihuida PHARMA Group Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Bioton

      • 19.17.1 Bioton Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Salix Pharmaceuticals

      • 19.18.1 Salix Pharmaceuticals Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Henan Tian Fang Pharmaceutical

      • 19.19.1 Henan Tian Fang Pharmaceutical Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    The List of Tables and Figures (Totals 80 Figures and 140 Tables)

    • Figure Product Picture

    • Figure Insulin Market Size and Growth Rate of Ultra-short-acting insulin Market, 2015 - 2026 (USD Million)

    • Figure Insulin Market Size and Growth Rate of Short-acting insulin Market, 2015 - 2026 (USD Million)

    • Figure Insulin Market Size and Growth Rate of In effect insulin Market, 2015 - 2026 (USD Million)

    • Figure Insulin Market Size and Growth Rate of Long-acting insulin Market, 2015 - 2026 (USD Million)

    • Figure Insulin Market Size and Growth Rate of Type 1 diabetes from 2014 to 2026

    • Figure Insulin Market Size and Growth Rate of Type 2 diabetes from 2014 to 2026

    • Figure Insulin Market Size and Growth Rate of Others diabetes from 2014 to 2026

    • Figure Germany Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure UK Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure France Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Insulin Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Insulin

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Insulin by Different Types from 2014 to 2026

    • Table Consumption Share of Insulin by Different Types from 2014 to 2026

    • Figure Insulin Market Size and Growth Rate of Ultra-short-acting insulin Market, 2015 - 2026 (USD Million)

    • Figure Insulin Market Size and Growth Rate of Short-acting insulin Market, 2015 - 2026 (USD Million)

    • Figure Insulin Market Size and Growth Rate of In effect insulin Market, 2015 - 2026 (USD Million)

    • Figure Insulin Market Size and Growth Rate of Long-acting insulin Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Insulin by Different End-Users from 2014 to 2026

    • Table Consumption Share of Insulin by Different End-Users from 2014 to 2026

    • Figure Insulin Market Size and Growth Rate of Type 1 diabetes from 2014 to 2026

    • Figure Insulin Market Size and Growth Rate of Type 2 diabetes from 2014 to 2026

    • Figure Insulin Market Size and Growth Rate of Others diabetes from 2014 to 2026

    • Table Europe Insulin Production by Major Regions

    • Table Europe Insulin Production Share by Major Regions

    • Figure Europe Insulin Production Share by Major Countries and Regions in 2014

    • Table Europe Insulin Consumption by Major Regions

    • Table Europe Insulin Consumption Share by Major Regions

    • Table Germany Insulin Production, Import, Consumption and Export Analysis

    • Table UK Insulin Production, Import, Consumption and Export Analysis

    • Table France Insulin Production, Import, Consumption and Export Analysis

    • Table Italy Insulin Production, Import, Consumption and Export Analysis

    • Table Spain Insulin Production, Import, Consumption and Export Analysis

    • Table Poland Insulin Production, Import, Consumption and Export Analysis

    • Table Russia Insulin Production, Import, Consumption and Export Analysis

    • Table Switzerland Insulin Production, Import, Consumption and Export Analysis

    • Table Turkey Insulin Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Insulin Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Insulin Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Insulin Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Insulin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Insulin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Insulin Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Insulin Consumption by Types from 2014 to 2026

    • Table Germany Insulin Consumption Share by Types from 2014 to 2026

    • Table Germany Insulin Consumption by End-Users from 2014 to 2026

    • Table Germany Insulin Consumption Share by End-Users from 2014 to 2026

    • Table UK Insulin Consumption by Types from 2014 to 2026

    • Table UK Insulin Consumption Share by Types from 2014 to 2026

    • Table UK Insulin Consumption by End-Users from 2014 to 2026

    • Table UK Insulin Consumption Share by End-Users from 2014 to 2026

    • Table France Insulin Consumption by Types from 2014 to 2026

    • Table France Insulin Consumption Share by Types from 2014 to 2026

    • Table France Insulin Consumption by End-Users from 2014 to 2026

    • Table France Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Italy Insulin Consumption by Types from 2014 to 2026

    • Table Italy Insulin Consumption Share by Types from 2014 to 2026

    • Table Italy Insulin Consumption by End-Users from 2014 to 2026

    • Table Italy Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Spain Insulin Consumption by Types from 2014 to 2026

    • Table Spain Insulin Consumption Share by Types from 2014 to 2026

    • Table Spain Insulin Consumption by End-Users from 2014 to 2026

    • Table Spain Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Poland Insulin Consumption by Types from 2014 to 2026

    • Table Poland Insulin Consumption Share by Types from 2014 to 2026

    • Table Poland Insulin Consumption by End-Users from 2014 to 2026

    • Table Poland Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Russia Insulin Consumption by Types from 2014 to 2026

    • Table Russia Insulin Consumption Share by Types from 2014 to 2026

    • Table Russia Insulin Consumption by End-Users from 2014 to 2026

    • Table Russia Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Insulin Consumption by Types from 2014 to 2026

    • Table Switzerland Insulin Consumption Share by Types from 2014 to 2026

    • Table Switzerland Insulin Consumption by End-Users from 2014 to 2026

    • Table Switzerland Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Insulin Consumption by Types from 2014 to 2026

    • Table Turkey Insulin Consumption Share by Types from 2014 to 2026

    • Table Turkey Insulin Consumption by End-Users from 2014 to 2026

    • Table Turkey Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Insulin Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Insulin Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Insulin Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Insulin Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Insulin Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Insulin Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Insulin Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Insulin Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Insulin Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Insulin Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Insulin Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Insulin Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Insulin Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Insulin Market Volume and Growth Rate from 2014 to 2026

    • Table Disha Pharmaceutical Group Profiles

    • Table Disha Pharmaceutical Group Production, Value, Price, Gross Margin 2014-2019

    • Table Disha Pharmaceutical Group Product benchmarking

    • Table Disha Pharmaceutical Group Strategic initiatives

    • Table Disha Pharmaceutical Group SWOT analysis

    • Table Novartis Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis Product benchmarking

    • Table Novartis Strategic initiatives

    • Table Novartis SWOT analysis

    • Table GEA Profiles

    • Table GEA Production, Value, Price, Gross Margin 2014-2019

    • Table GEA Product benchmarking

    • Table GEA Strategic initiatives

    • Table GEA SWOT analysis

    • Table Dongbao Profiles

    • Table Dongbao Production, Value, Price, Gross Margin 2014-2019

    • Table Dongbao Product benchmarking

    • Table Dongbao Strategic initiatives

    • Table Dongbao SWOT analysis

    • Table MannKind Profiles

    • Table MannKind Production, Value, Price, Gross Margin 2014-2019

    • Table MannKind Product benchmarking

    • Table MannKind Strategic initiatives

    • Table MannKind SWOT analysis

    • Table Gan & Lee Profiles

    • Table Gan & Lee Production, Value, Price, Gross Margin 2014-2019

    • Table Gan & Lee Product benchmarking

    • Table Gan & Lee Strategic initiatives

    • Table Gan & Lee SWOT analysis

    • Table Emisphere Profiles

    • Table Emisphere Production, Value, Price, Gross Margin 2014-2019

    • Table Emisphere Product benchmarking

    • Table Emisphere Strategic initiatives

    • Table Emisphere SWOT analysis

    • Table Boehringer Ingelheim Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Boehringer Ingelheim Product benchmarking

    • Table Boehringer Ingelheim Strategic initiatives

    • Table Boehringer Ingelheim SWOT analysis

    • Table Merck Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Merck Product benchmarking

    • Table Merck Strategic initiatives

    • Table Merck SWOT analysis

    • Table United Laboratories (TUL) Profiles

    • Table United Laboratories (TUL) Production, Value, Price, Gross Margin 2014-2019

    • Table United Laboratories (TUL) Product benchmarking

    • Table United Laboratories (TUL) Strategic initiatives

    • Table United Laboratories (TUL) SWOT analysis

    • Table Sanofi Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Product benchmarking

    • Table Sanofi Strategic initiatives

    • Table Sanofi SWOT analysis

    • Table Eli Lilly Profiles

    • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

    • Table Eli Lilly Product benchmarking

    • Table Eli Lilly Strategic initiatives

    • Table Eli Lilly SWOT analysis

    • Table Bristol-Myers Squibb Profiles

    • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

    • Table Bristol-Myers Squibb Product benchmarking

    • Table Bristol-Myers Squibb Strategic initiatives

    • Table Bristol-Myers Squibb SWOT analysis

    • Table Novo Nordisk Profiles

    • Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019

    • Table Novo Nordisk Product benchmarking

    • Table Novo Nordisk Strategic initiatives

    • Table Novo Nordisk SWOT analysis

    • Table Takeda Pharmaceutical Company Profiles

    • Table Takeda Pharmaceutical Company Production, Value, Price, Gross Margin 2014-2019

    • Table Takeda Pharmaceutical Company Product benchmarking

    • Table Takeda Pharmaceutical Company Strategic initiatives

    • Table Takeda Pharmaceutical Company SWOT analysis

    • Table Shihuida PHARMA Group Profiles

    • Table Shihuida PHARMA Group Production, Value, Price, Gross Margin 2014-2019

    • Table Shihuida PHARMA Group Product benchmarking

    • Table Shihuida PHARMA Group Strategic initiatives

    • Table Shihuida PHARMA Group SWOT analysis

    • Table Bioton Profiles

    • Table Bioton Production, Value, Price, Gross Margin 2014-2019

    • Table Bioton Product benchmarking

    • Table Bioton Strategic initiatives

    • Table Bioton SWOT analysis

    • Table Salix Pharmaceuticals Profiles

    • Table Salix Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Salix Pharmaceuticals Product benchmarking

    • Table Salix Pharmaceuticals Strategic initiatives

    • Table Salix Pharmaceuticals SWOT analysis

    • Table Henan Tian Fang Pharmaceutical Profiles

    • Table Henan Tian Fang Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Henan Tian Fang Pharmaceutical Product benchmarking

    • Table Henan Tian Fang Pharmaceutical Strategic initiatives

    • Table Henan Tian Fang Pharmaceutical SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US